← All organizations

AlgoRx Pharmaceuticals

For profitContributed to NME

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Last known activity

Sep 1, 2005

Acquired by Anesiva, Inc. on Sep 26, 2005

Timeline

2000s

Jun 1, 2001
AlgoRx Pharmaceuticals— Founded
Sep 26, 2005
Anesiva, Inc.— Acquired By

Drugs by trial phase (2 distinct, 8 trials)

Phase 3 (1 own, 0 via acquisition)

lidocaine

Phase 2 (1 own, 0 via acquisition)

capsaicin

Indications

Studied for

Recent trials (8)

NCT00146198Lead sponsorPhase 2Sep 1, 2005
NCT00132392Lead sponsorPhase 2Jul 1, 2005
NCT00133133Lead sponsorPhase 2Jul 1, 2005
NCT00146185Lead sponsorPhase 3Feb 1, 2005
NCT00140088Lead sponsorPhase 3Dec 1, 2004
NCT00130949Lead sponsorPhase 2Nov 1, 2004
NCT00130962Lead sponsorPhase 2Sep 1, 2004
NCT00132405Lead sponsorPhase 2May 1, 2004

Details

Founded: Secaucus, NJ, US Jun 1, 2001
Last known activity: Sep 1, 2005